Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hydrochloride, Tocainide
2. Tocainide
3. Tocainide Monohdyrochloride, (r)-isomer
4. Tocainide Monohydrobromide, (r)-isomer
5. Tocainide Monohydrochloride
6. Tocainide Monohydrochloride, (+-)-isomer
7. Tocainide Monohydrochloride, (s)-isomer
8. Tocainide, (+-)-isomer
9. Tocainide, (r)-isomer
10. Tocainide, (s)-isomer
11. Tonocard
12. W 36095
13. W-36095
14. W36095
15. Xylotocan
1. 71395-14-7
2. Tocainide Hcl
3. 35891-93-1
4. Tonocard
5. Tocainide Monohydrochloride
6. 2-amino-n-(2,6-dimethylphenyl)propanamide;hydrochloride
7. 2-amino-n-(2,6-dimethylphenyl)propanamide Hydrochloride
8. Tocainide Hydrochloride [usp]
9. 2k7i38ckn5
10. Tocainide (hydrochloride)
11. Propanamide, 2-amino-n-(2,6-dimethylphenyl)-, Monohydrochloride
12. Dsstox_cid_25540
13. Dsstox_rid_80942
14. Dsstox_gsid_45540
15. Tocainide Hydrochloride (usp)
16. Taquidil
17. Xylotocan
18. Cas-35891-93-1
19. Tocainide-hydrochloride
20. Unii-2k7i38ckn5
21. Tonocard (tn)
22. Einecs 275-361-2
23. 2-amino-n-(2,6-dimethylphenyl)propanamide Monohydrochloride
24. Ncgc00017005-01
25. 2-amino-2',6'-propionoxylidide Hydrochloride
26. Schembl122779
27. Tocainide Hydrochloride- Bio-x
28. Chembl1200773
29. Dtxsid5045540
30. Hy-b1798a
31. Hms1571m15
32. Tocainide (+-)-form Hydrochloride
33. Tox21_110732
34. Tox21_500344
35. Tox21_110732_1
36. Ccg-213604
37. Lp00344
38. Tocainide Hydrochloride [mart.]
39. Tocainide Hydrochloride [vandf]
40. Tocainide Hydrochloride [who-dd]
41. Ncgc00162129-06
42. Ncgc00261029-01
43. Bt164480
44. Tocainide (+/-)-form Hydrochloride
45. Cs-0013838
46. Tocainide Hydrochloride [orange Book]
47. Tocainide Hydrochloride [usp Impurity]
48. D02088
49. 6-bromo-4-quinazolinecarboxylic Acidammonium Salt
50. Tocainide Hydrochloride, >=98% (hplc), Solid
51. Sr-01000763682
52. Tocainide (+/-)-form Hydrochloride [mi]
53. Sr-01000763682-3
54. Q27254865
55. (1)-2-amino-n-(2,6-dimethylphenyl)propionamide Hydrochloride
56. Propanamide, 2-amino-n-(2,6-dimethylphenyl)-, Monohydrochloride, (+-)-
57. Tocainide Hydrochloride, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 228.72 g/mol |
|---|---|
| Molecular Formula | C11H17ClN2O |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 228.1029409 g/mol |
| Monoisotopic Mass | 228.1029409 g/mol |
| Topological Polar Surface Area | 55.1 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 196 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)
REF. STANDARDS & IMPURITIES
USP
ABOUT THIS PAGE
A Tocainide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tocainide, including repackagers and relabelers. The FDA regulates Tocainide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tocainide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tocainide supplier is an individual or a company that provides Tocainide active pharmaceutical ingredient (API) or Tocainide finished formulations upon request. The Tocainide suppliers may include Tocainide API manufacturers, exporters, distributors and traders.
click here to find a list of Tocainide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tocainide DMF (Drug Master File) is a document detailing the whole manufacturing process of Tocainide active pharmaceutical ingredient (API) in detail. Different forms of Tocainide DMFs exist exist since differing nations have different regulations, such as Tocainide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tocainide DMF submitted to regulatory agencies in the US is known as a USDMF. Tocainide USDMF includes data on Tocainide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tocainide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tocainide suppliers with USDMF on PharmaCompass.
Tocainide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tocainide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tocainide GMP manufacturer or Tocainide GMP API supplier for your needs.
A Tocainide CoA (Certificate of Analysis) is a formal document that attests to Tocainide's compliance with Tocainide specifications and serves as a tool for batch-level quality control.
Tocainide CoA mostly includes findings from lab analyses of a specific batch. For each Tocainide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tocainide may be tested according to a variety of international standards, such as European Pharmacopoeia (Tocainide EP), Tocainide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tocainide USP).
LOOKING FOR A SUPPLIER?
